GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jinxin Fertility Group 1951.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

2.31

-0.86%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Jinxin Fertility Group

Its shares trade on HKEX under the ticker 1951.HK. It has been listed since 25 June 2019. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.00bn and a net loss of CN¥1.11bn. At that date it held total assets of CN¥16.26bn and shareholders' equity of CN¥10.65bn.

Jinxin Fertility Group Ltd. engages in the provision of assisted reproductive, management and ancillary medical services. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2019-06-25. The firm operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The firm mainly operates its business in China and the Unites.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
25 Jun 2019
Employees
1,247

Leadership

Pay as last reported

  • Mr. Yong ZhongExecutive Chairman of the Board, since 2018CN¥6.2m
  • Mr. Yang DongChief Executive Officer, Executive Director, since 2018CN¥5.7m
  • Ms. Rong LyuCo-Chief Executive Officer, Executive Director, since 2021CN¥5.8m
  • Ms. Hanmei HuangChief Financial Officer
  • Ms. Xiaoqing YanSenior Vice President, Non-Executive Director, since 2018CN¥965,000
  • Dr. Lihong GengExecutive Director, since 2021CN¥1.8m
  • Dr. John WilcoxExecutive Director, since 2018CN¥16.2m
  • Ms. Hongmei DuanChief Operating Officer - Domestic Market
  • Dr. Yuan LiChief Medical Officer
  • Ms. Sau Mei NgJoint Company Secretary
  • Ms. Yangyang ZhaiJoint Company Secretary
  • Mr. Min FangNon-Executive Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
64
Environment
85
Social
78
Governance
28
Direct emissions (scope 1)
1,275.14 t
Energy emissions (scope 2)
10,836.47 t
Women in the workforce
83.26%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Jinxin Fertility Group Ltd has several key strengths that contribute to its competitive advantage:

Weaknesses

  • Despite its strengths, Jinxin Fertility Group Ltd faces certain weaknesses that may pose challenges:

Opportunities

  • Jinxin Fertility Group Ltd can capitalize on the following opportunities to further expand and strengthen its position:

Threats

  • Jinxin Fertility Group Ltd should be aware of the following threats that could impact its business:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.